SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-20-006095
Filing Date
2020-04-09
Accepted
2020-04-09 09:30:02
Documents
13

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 7542755
2 image_001.jpg GRAPHIC 18512
3 image_002.jpg GRAPHIC 8694
4 image_011.jpg GRAPHIC 32522
5 image_004.jpg GRAPHIC 15659
6 image_005.jpg GRAPHIC 9238
7 image_006.jpg GRAPHIC 10021
8 image_007.jpg GRAPHIC 8084
9 image_008.jpg GRAPHIC 9656
10 image_014.jpg GRAPHIC 20304
11 image_009.jpg GRAPHIC 22902
12 image_012.jpg GRAPHIC 3572
13 image_015.jpg GRAPHIC 4690
  Complete submission text file 0001493152-20-006095.txt   7770712
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-236235 | Film No.: 20783347
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences